St. Joseph Hospital Orange
Orange, California 92868-3849
2 studies enrolling now · 12 studies all time
What they study most
AMI Cardiogenic Shock, Acute Coronary Syndrome, Acute Myocardial Infarction, Angina Pectoris, Atherosclerosis, Coronary, Breast Cancer, Cardiogenic Shock, Childhood Germ Cell Tumor, Coronary Artery Disease, Coronary Vessel Occlusion, Extragonadal Germ Cell Tumor, Heart Attack
Studies at this site
- A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head) — Recruiting now
- Assessment of Support With Impella® Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic Shock — Recruiting now
- Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function — Running, not enrolling
- A Trial to Learn How the Combination of Fianlimab With Cemiplimab and Chemotherapy Works Compared With Cemiplimab and Chemotherapy for Treating Adult Patients With Advanced Non-small Cell Lung Cancer — Running, not enrolling
- Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions — Completed
- National Cardiogenic Shock Initiative — Completed
- Study of the CAT RX Aspiration Catheter When Used in Patients With Large Occlusive Thrombus in Coronary Arteries — Completed
- Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast Cancer — Completed
- S9920 Busulfan Compared With Cyclophosphamide in Patients Undergoing Total-Body Irradiation Plus Peripheral Stem Cell Transplantation for Advanced Myelodysplastic Syndrome or Related Acute Myeloid Leukemia — Completed
- Marimastat in Treating Patients With Stage III Non-small Cell Lung Cancer — Completed
- Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia — Status unconfirmed
- Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors — Completed